The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neuroimmunology

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0165-5728(02)00353-3PMID 12446022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon-beta-1b increases serum interleukin-12 p40 levels in primary progressive multiple sclerosis patients.

  2002cited by this paper
• [Cytokine production in patients with chronic viral hepatitis C during treatment with interferon-alpha].

  2001cited by this paper
• Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis.

  2001cited by this paper
• Immunologic therapy for secondary and primary progressive multiple sclerosis

  2001cited by this paper
• EXPRESSION OF TNF-α mRNA BY PERIPHERAL BLOOD MONONUCLEAR CELLS OF MULTIPLE SCLEROSIS PATIENTS TREATED WITH IFN-β 1A

  2001cited by this paper
• Measurement of intracellular cytokines in MS patients treated with β-interferon and association of a β-interferon induced exacerbation with increased expression of γ-interferon by monocytes

  2001cited by this paper
• Interferon-beta induces the development of type 2 dendritic cells.

  2001cited by this paper
• Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.

  2001cited by this paper
• Measurement of intracellular cytokines in MS patients treated with beta-interferon and association of a beta-interferon induced exacerbation with increased expression of gamma-interferon by monocytes.

  2001cited by this paper
• Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease.

  2000cited by this paper
• SHORT-TERM TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS WITH INTERFERON (IFN)-β1B TRANSIENTLY INCREASES THE BLOOD LEVELS OF INTERLEUKIN (IL)-6, IL-10 AND IFN-γ WITHOUT SIGNIFICANTLY MODIFYING THOSE OF IL-1β, IL-2, IL-4 AND TUMOUR NECROSIS FACTOR-α

  2000cited by this paper
• Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.

  2000cited by this paper
• Blood monocyte phenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and patients with chronic renal failure.

  2000cited by this paper
• Diagnostic criteria for primary progressive multiple sclerosis: A position paper

  2000cited by this paper
• Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus

  2000cited by this paper
• Increased levels of circulating soluble CD14 in Kawasaki disease

  2000cited by this paper
• Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: upregulation during bacterial infections and viral meningitis.

  1999cited by this paper
• Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

  1999cited by this paper
• Soluble (s) CD14 and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before and after treatment with interferon (IFN)-alpha.

  1998cited by this paper
• Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.

  1998cited by this paper
• Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development.

  1998cited by this paper
• Human CD14 mediates recognition and phagocytosis of apoptotic cells

  1998cited by this paper
• Apoptosis: Phagocytic docking without shocking

  1998cited by this paper
• Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro.

  1997cited by this paper
• Monocyte activity in Behçet's disease.

  1996cited by this paper
• Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis.

  1996cited by this paper
• Interferon β-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis

  1996cited by this paper
• Monocyte/macrophage differentiation in early multiple sclerosis lesions

  1995cited by this paper
• Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

  1995cited by this paper
• Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV‐infected patients

  1994cited by this paper
• Gamma-interferon: physiology and speculation on its role in medicine.

  1987cited by this paper

• TAFRO Syndrome Triggered by Vaccination against SARS-CoV-2 (mRNA1273).

  2025cites this paper
• sCD14, a marker of immune-inflammation can help to distinguish between psychotic disorders with and without disordered social interaction

  2023cites this paper
• Effect of gluten-free diet on levels of soluble CD14 and lipopolysaccharide-binding protein in adult patients with celiac disease

  2021cites this paper
• Different neuroinflammatory gene expression profiles in highly active and benign multiple sclerosis.

  2021cites this paper
• Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis.

  2020cites this paper
• Cerebrospinal Fluid Microglial Activation Markers in Patients With Neuromyelitis Optica

  2020cites this paper
• Elevated serum levels of soluble CD14 in HBeAg‐positive chronic HBV patients upon Peginterferon treatment are associated with treatment response

  2019cites this paper
• Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects

  2019cites this paper
• Decreased Expression of CD14 in MSU-Mediated Inflammation May Be Associated with Spontaneous Remission of Acute Gout

  2019cites this paper
• YKL-40 IS A CSF BIOMARKER OF INTRATHECAL INFLAMMATION IN SECONDARY

  2019cites this paper
• Primary Progressive Multiple Sclerosis: Putting Together the Puzzle

  2017cites this paper
• Endotoxemia is associated with acute coronary syndrome in patients with end stage kidney disease

  2017influential citation
• Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges.

  2017cites this paper
• New roles for CD14 and IL‐β linking inflammatory dendritic cells to IL‐17 production in memory CD4+ T cells

  2016cites this paper
• YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.

  2016cites this paper
• RETRACTED ARTICLE: Polymorphisms in CD14 Gene May Modify Soluble CD14 Levels and Represent Risk Factors for Multiple Sclerosis

  2016cites this paper
• Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.

  2015cites this paper
• R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice

  2014cites this paper
• Genetische Varianten von CD14 und deren Einfluss auf die Empfänglichkeit für Lungentuberkulose bei einer Studienpopulation aus Ghana, Westafrika

  2014cites this paper
• Impaired Functions of Macrophage from Cystic Fibrosis Patients: CD11b, TLR-5 Decrease and sCD14, Inflammatory Cytokines Increase

  2013cites this paper
• Lack of association of the CD14/C -- 159T polymorphism with susceptibility and progression parameters in Turkish multiple sclerosis patients.

  2012cites this paper
• Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients

  2012cites this paper
• Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease

  2012cites this paper
• Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis.

  2012cites this paper
• Biomarkers in Multiple Sclerosis

  2011cites this paper
• Novel Sensitive Real-Time PCR for Quantification of Bacterial 16S rRNA Genes in Plasma of HIV-Infected Patients as a Marker for Microbial Translocation

  2011cites this paper
• Chapter 6 - Biomarkers in Multiple Sclerosis

  2010cites this paper
• CD14 Mediates Cross Talk between Mononuclear Cells and Fibroblasts for Upregulation of Matrix Metalloproteinase 9 by Borrelia burgdorferi

  2007cites this paper
• Biological markers for multiple sclerosis.

  2007cites this paper
• Interferon‐β1b treatment modulates cytokines in patients with primary progressive multiple sclerosis

  2006cites this paper
• The LPS Receptor, CD14 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

  2006cites this paper
• The Envelope Protein of a Human Endogenous Retrovirus-W Family Activates Innate Immunity through CD14/TLR4 and Promotes Th1-Like Responses1

  2006cites this paper
• The LPS receptor, CD14, in experimental autoimmune encephalomyelitis and multiple sclerosis.

  2006cites this paper
• Innate Immunity through CD 14 / TLR 4 and Endogenous Retrovirus-W Family Activates The Envelope Protein of a Human

  2006cites this paper
• Increased serum levels of soluble CD14 indicate stable multiple sclerosis.

  2006influential citation
• Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.

  2006cites this paper
• The Envelope Protein of a HERV-W family Human Retrovirus Activates Innate Immunity Through CD 14 / TLR 4 and Promotes Th 1 Like Responses

  2006cites this paper
• Biomarkers in Multiple Sclerosis

  2006cites this paper
• Antiviral Treatment with Alpha Interferon Up-Regulates CD14 on Liver Macrophages and Its Soluble Form in Patients with Chronic Hepatitis B

  2005cites this paper
• CD14 receptor polymorphism and Alzheimer's disease risk.

  2005cites this paper
• Die Bedeutung des Liquorbefundes in der Diagnostik der Multiplen Sklerose

  2005cites this paper
• Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin

  2004cites this paper
• CD14 gene promoter polymorphism in different clinical forms of tuberculosis.

  2004cites this paper
• Demyelinating diseases Neutralizing antibodies to beta-IFN: implications forMSmanagement Review:Neutralizingantibodies to interferonbeta: implications for the management of multiple sclerosis (pp 241–246)

  2004cites this paper
• Decreased CD14+CCR2+ monocytes in active multiple sclerosis.

  2004cites this paper